Uterine (or endometrial) cancer is the most common type of gynecologic cancer, with more than 886,000 women living with the disease in the U.S., according to National Cancer Institute’s SEER Cancer Statistics. As Ovarian Cancer Research Alliance funds research that aims to cure ovarian and related gynecologic cancers, we are here for those impacted by … Continued
In a wide-ranging interview on the podcast Out of Patients with Matthew Zachary, OCRA’s President & CEO Audra Moran delves into the evolution of the organization, the unique programs offered by OCRA such as our peer mentorship program Woman to Woman, and thoughts on how AI may revolutionize ovarian cancer research. Listen to the podcast … Continued
The Food and Drug Administration has granted accelerated approval to Avmapki Fakzynja Co-pack (avutometinib capsules; defactinib tablets), made by Verastem Oncology, making it the first FDA-approved treatment for patients with recurrent low-grade serous ovarian cancer (LGSOC) who have a KRAS mutation. The approval is based on the results of the Phase 2 RAMP 201 clinical … Continued
Liliana is a mother, a wife, a dedicated volunteer and a former physician. While her cancer diagnosis forced her into early retirement, her mission to help others never wavered. Today, OCRA programs made possible by donor generosity, allow her to give back and make someone else’s journey a little easier, all while healing a part … Continued
News of the newly launched Global Ovarian Cancer Research Consortium — and its inaugural AI Accelerator Grant — is spreading quickly, with media outlets across the country taking notice. The AI Accelerator Grant will award $1 million in funding, along with $1 million in compute support from Microsoft’s AI for Good Lab, to international research … Continued
Four leading ovarian cancer research charities from four countries are funding a new AI Accelerator Grant in partnership with Microsoft’s AI for Good Lab to supercharge the next cancer research breakthrough. [May 8, 2025] – Today marks World Ovarian Cancer Day and the launch of the Global Ovarian Cancer Research Consortium — a first-of-its-kind alliance uniting … Continued
In the newest installment of our continuing introduction of our 2025 grantees, Ovarian Cancer Research Alliance (OCRA) is proud to highlight the three recipients of our 2025 Health Equity Research Grants, part of the $6 million in new research OCRA is funding this year. These grants support research focused on identifying and addressing disparities in ovarian … Continued
On behalf of the millions of Americans living with cancer and at risk for being diagnosed, as well as health care providers, researchers, advocates, and their communities, we express our profound disappointment and grave concern regarding the proposed elimination of the Centers for Disease Control and Prevention’s Division of Cancer Prevention and Control (DCPC) in … Continued
Research Breakthrough: A team of researchers at The University of Texas Health Science Center developed a pioneering AI tool to better predict treatment response, a step toward earlier personalized treatment plans. The researchers created a new artificial intelligence tool that uses images from diagnostic laparoscopy, minimally invasive camera-made images taken inside the abdomen, to predict how patients … Continued
Ovarian Cancer Research Alliance (OCRA) has announced that registration for its International Gynecologic Cancer Conference, taking place online from September 15–17, 2025, will be free for all attendees. This annual online event is designed for anyone impacted by gynecologic cancers — patients, survivors, caregivers, and advocates. You’ll hear from leading researchers and clinicians, connect with others who understand … Continued
Ovarian Cancer Research Alliance (OCRA) has expanded its educational programming, offering new opportunities for patients and survivors to connect, learn, and stay informed. RoundtablesRoundtables are 90-minute discussions focused on common challenges faced after diagnosis, providing strategies for coping and connection with others who understand. Register for Roundtables. WorkshopsWorkshops are “Ovarian Cancer 101,” providing vital foundational … Continued
A new article from Patient Power highlights findings from a paper authored by Ovarian Cancer Research Alliance (OCRA) and Komodo Health, that reveals significant gaps in genetic testing for ovarian cancer patients. Chad Ramsey, OCRA’s Vice President of Policy, spoke with Patient Power about the study’s results and the urgent need to close these gaps. … Continued
Get email updates about research news, action alerts, and ways to join the fight.
